Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

264 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club.
Bergmann P, Body JJ, Boonen S, Boutsen Y, Devogelaer JP, Goemaere S, Kaufman JM, Reginster JY, Gangji V; Members of Advisory Board on Bone Markers. Bergmann P, et al. Among authors: devogelaer jp. Int J Clin Pract. 2009 Jan;63(1):19-26. doi: 10.1111/j.1742-1241.2008.01911.x. Int J Clin Pract. 2009. PMID: 19125989 Free PMC article. Review.
Non-pharmacological management of osteoporosis: a consensus of the Belgian Bone Club.
Body JJ, Bergmann P, Boonen S, Boutsen Y, Bruyere O, Devogelaer JP, Goemaere S, Hollevoet N, Kaufman JM, Milisen K, Rozenberg S, Reginster JY. Body JJ, et al. Among authors: devogelaer jp. Osteoporos Int. 2011 Nov;22(11):2769-88. doi: 10.1007/s00198-011-1545-x. Epub 2011 Mar 1. Osteoporos Int. 2011. PMID: 21360219 Free PMC article. Review.
The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club.
Cavalier E, Bergmann P, Bruyère O, Delanaye P, Durnez A, Devogelaer JP, Ferrari SL, Gielen E, Goemaere S, Kaufman JM, Toukap AN, Reginster JY, Rousseau AF, Rozenberg S, Scheen AJ, Body JJ. Cavalier E, et al. Among authors: devogelaer jp. Osteoporos Int. 2016 Jul;27(7):2181-2195. doi: 10.1007/s00198-016-3561-3. Epub 2016 Mar 30. Osteoporos Int. 2016. PMID: 27026330
Zoledronic acid efficacy and safety over five years in postmenopausal osteoporosis.
Devogelaer JP, Brown JP, Burckhardt P, Meunier PJ, Goemaere S, Lippuner K, Body JJ, Samsioe G, Felsenberg D, Fashola T, Sanna L, Ortmann CE, Trechsel U, Krasnow J, Eriksen EF, Garnero P. Devogelaer JP, et al. Osteoporos Int. 2007 Sep;18(9):1211-8. doi: 10.1007/s00198-007-0367-3. Epub 2007 May 22. Osteoporos Int. 2007. PMID: 17516022 Free article. Clinical Trial.
Post hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosis.
Roux C, Reid DM, Devogelaer JP, Saag K, Lau CS, Reginster JY, Papanastasiou P, Bucci-Rechtweg C, Su G, Sambrook PN. Roux C, et al. Among authors: devogelaer jp. Osteoporos Int. 2012 Mar;23(3):1083-90. doi: 10.1007/s00198-011-1800-1. Osteoporos Int. 2012. PMID: 21975559 Clinical Trial.
264 results